First, the presence of microglia with a regenerative (CD163+IBA1+) or pro-inflammatory (iNOS+IBA1+) activation state (13, 14) was assessed in different MS lesion (sub)types (Figure 1). This evidence concerns the gene CD163 and myeloid sarcoma.